Neil E Hubbard Selected Research

Neil E Hubbard Research Topics

Disease

23	Neoplasms (Cancer) 10/2021 - 04/2004
11	Breast Neoplasms (Breast Cancer) 10/2021 - 04/2004
9	Carcinogenesis 10/2021 - 02/2003
4	Neoplasm Metastasis (Metastasis) 01/2006 - 04/2004
2	Hyperthermia 10/2019 - 10/2019
2	Colonic Neoplasms (Colon Cancer) 10/2005 - 02/2005
1	Adenocarcinoma 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Necrosis 10/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Carcinoma (Carcinomatosis) 09/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Disease Progression 07/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2005
1	Rheumatoid Arthritis 04/2005

Drug/Important Bio-Agent (IBA)

7	Conjugated Linoleic AcidsIBA 04/2010 - 02/2003
4	AntigensIBA 10/2019 - 04/2013
4	Estrogen ReceptorsIBA 09/2017 - 05/2014
4	Linoleic Acid (Linoleate)IBA 06/2007 - 02/2005
3	Liposomes (Liposome)IBA 10/2019 - 12/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2005
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2010 - 02/2005
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2019 - 01/2017
2	CytokinesIBA 10/2019 - 01/2015
2	Interferon Type IIBA 10/2019 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2016 - 05/2014
2	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 10/2005 - 02/2005
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 10/2005 - 02/2005
1	Protein Isoforms (Isoforms)IBA 10/2021
1	AndrogensIBA 06/2021
1	Prolactin Receptors (Prolactin Receptor)IBA 06/2021
1	Progesterone FDA LinkGeneric 06/2021
1	Gemcitabine FDA Link 10/2019
1	CopperIBA 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	Toll-Like Receptor AgonistsIBA 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	VimentinIBA 01/2018
1	Conditioned Culture MediaIBA 09/2017
1	Chemotactic FactorsIBA 09/2017
1	Phenobarbital (Luminal)FDA Link 09/2017
1	2- (2- (2- chloro- 3- (2- (3,3- dimethyl- 5- sulfo- 1- (4- sulfo- butyl)- 3H- indol- 2- yl)- vinyl)- cyclohex- 2- enylidene)- ethylidene)- 3,3- dimethyl- 1- (4- sulfo- butyl)- 2,3- dihydro- 1H- indole- 5- carboxylic acidIBA 01/2016
1	2',7'- bis(carboxyethyl)- 5(6)- carboxyfluoresceinIBA 01/2016
1	Coloring Agents (Dyes)IBA 01/2016
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2016
1	Protons (Proton)IBA 01/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2016
1	Carbonic Anhydrase IXIBA 01/2016
1	6-carboxyfluorescein (carboxyfluorescein)IBA 01/2016
1	Peptides (Polypeptides)IBA 07/2015
1	Contrast MediaIBA 07/2015
1	Complement System Proteins (Complement)IBA 07/2015
1	Neuropilin-1IBA 07/2015
1	LipidsIBA 07/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2015
1	Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)IBA 01/2015
1	Hematoxylin (Haematoxylon)IBA 01/2015
1	Hormones (Hormone)IBA 05/2014
1	Formaldehyde (Formol)FDA Link 05/2014
1	human ERBB2 proteinIBA 05/2014
1	Fixatives (Pickling Agents)IBA 04/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2010
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 12/2007
1	Benzo(a)pyreneIBA 12/2007
1	Messenger RNA (mRNA)IBA 06/2007
1	Matrix Metalloproteinases (MMPs)IBA 06/2007
1	Enzyme ActivatorsIBA 06/2007
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2007
1	EnzymesIBA 06/2007
1	Dietary Fats (Dietary Fat)IBA 01/2006
1	Palmitic AcidsIBA 01/2006
1	Plant Oils (Vegetable Oils)IBA 01/2006
1	tallowIBA 01/2006
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 10/2005
1	AngiopoietinsIBA 04/2005
1	Lipoxygenase (Lipoxygenase-1)IBA 02/2005
1	Lipoxygenase InhibitorsIBA 02/2005
1	SmokeIBA 04/2004

Therapy/Procedure

3	Immunotherapy 10/2019 - 01/2017
3	Therapeutics 01/2017 - 07/2015
1	Induced Hyperthermia (Thermotherapy) 10/2019
1	Intravenous Injections 10/2019
1	Drug Therapy (Chemotherapy) 10/2019
1	Play Therapy (Therapy, Play) 01/2017
1	Microbubbles 07/2015
1	Aftercare (After-Treatment) 06/2007